Comprehensive care for inflammatory bowel diseases (IBD)
We look forward to providing you with professional inflammatory bowel disease treatment in Dallas and Lubbock in a friendly and welcoming environment. We are a member of Baylor Scott & White Health. We work closely with Baylor Scott & White North Texas Colon and Rectal Associates to bring you comprehensive IBD care.
Baylor Scott & White has established agreements with several types of insurance to ensure your health needs are covered.
Aetna - (25)Medicare Advantage PlansAetna Signature AdministratorsSelectChoice POS IIHealth Network OptionAetna Medicare Eagle II (PPO)Aetna Medicare Choice Plan (PPO)Aetna Medicare Choice II Plan (PPO)Group Retiree Medicare PPO - Limited to Exxon/MobilCHIPQPOSOpen Access SelectOpen Access Managed ChoiceAetna Medicare Freedom Preferred Plan (PPO)Aetna Medicare Prime Plan (HMO)Aetna Medicare Freedom Plan (PPO)Aetna Medicare Dual Complete Plan (HMO D-SNP)Health Network OnlyHMOManaged ChoiceOpen Access Elect ChoiceAetna Medicare Eagle Plan (PPO)Open Choice PPOAetna Medicare Value Plan (HMO)STAR
American Health Advantage of Texas - (1)American Health Advantage of Texas HMO I-SNP
Baylor Scott & White Health Plan - (1)BSW Premier HMO-Group
Blue Cross Blue Shield - (28)Blue Advantage HMOBlue Choice PPOBlue PremierBlue Premier Open Access HMOMedicare Advantage - OncorParPlanTraditionalIndemnityBlue EssentialsFederal FEP Blue FocusFederal Standard OptionBlue ChoiceHigh Performance NetworkBlue Cross Group Medicare Advantage (PPO)TRS-Care StandardTRS-ActiveCare Primary HDTRS-ActiveCare PrimaryTRS-ActiveCare 2Blue Advantage - SilverBlue Advantage - GoldBlue Advantage - BronzeTRS-ActiveCare Primary+HealthSelectBlue Cross Medicare Advantage (HMO)Blue Advantage Plus - SilverConsumer Directed HealthSelectFederal Basic OptionBlue Premier Access
Cigna - (12)Children's Medical Center Employee PlanCity of Dallas Employee PlanLocalPlusOpen Access PlusOpen Access Plus In-NetworkPoint of Service Open AccessCigna HealthSpringOpen AccessChoice FundBSW Extended PPOCigna Medicare AdvantageLocalPlus In-Network
DFW ConnectedCare - (1)American Airlines Employee Benefit Plan
EHN - (1)Employers Health Network
First Health/Coventry - (1)First Health/Coventry Network
HealthSmart - (2)ACCEL NetworkPreferred Network
Humana - (10)ChoiceCareHumana PreferredNational POSCommercial PPO PlansHumana Gold Plus SNP-DE (HMO D-SNP)HumanaChoice (Regional PPO)HumanaChoice (PPO)Humana USAA Honor with Rx (PPO)Humana Honor (PPO)Humana Gold Choice (PFFS)
Imagine Health - (1)Imagine Health Network
Nebraska Furniture Mart - (1)Pearl
Parkland Community Health Plan - (4)CHIP MedicaidHealthFirst MedicaidCHIPSTAR - HealthFirst
PHCS Network - (1)PHCS Primary PPO
Scott & White Health Plan - (2)Cigna PPO Network - Out-of-Area Member PlanMcLane Group Network
Superior Health Plan - (6)STAR+PLUSWellcareWellcare by AllwellAmbetter Core EPO - SilverAmbetter Core EPO - BronzeAmbetter Core EPO - Gold
Superior HealthPlan - (3)Medicare/Medicaid Dual Needs Plan: Advantage HMO SNPMedicare/Medicaid PlanSTAR+PLUS
TriWest HealthCare - (1)Community Care Network
United Healthcare - (23)All SaversCharterCharter BalancedCharter PlusChoice PlusCoreChoiceNavigate BalancedNavigateCore EssentialEDGENavigate PlusNexus ACO - Open AccessNexus ACO - Referral RequiredOptionsSelect PlusUnitedHealthcare Group Medicare Advantage (PPO)AARP Medicare Advantage Choice (PPO)AARP Medicare Advantage SecureHorizons Plan 2 (HMO-POS)AARP Medicare Advantage Walgreens (PPO)UnitedHealthcare Medicare Advantage Choice (Regional PPO)SelectAARP Medicare Advantage SecureHorizons Plan 1 (HMO-POS)
UnitedHealth - (2)Nexus ACO OANexusACO R
University Mary Hardin-Baylor - (1)Employee Benefit Plan
We couldn’t find any results for ""
Baylor Scott & White Center for Inflammatory Bowel Diseases offers expertise and IBD treatment options conveniently located near you.
Crohn's disease is an inflammatory bowel disease (IBD) in which chronic inflammation causes damage to the gastrointestinal tract, typically the small intestine and/or the colon. There is no medical or surgical cure for Crohn's disease at the present time.Learn more about Crohn's disease
We specialize in the diagnosis and treatment of inflammatory bowel disease, including Crohn's disease and ulcerative colitis.
We perform a variety of procedures to diagnosis and monitor the digestive tract:
- Capsule study
- Upper endoscopy (EGD)
In addition, we offer infusion therapies to manage symptoms:
Ulcerative colitis is an inflammatory bowel disease (IBD) in which inflammation causes damage to the large intestine—the colon and rectum. It is a chronic disease without medical cure at the present time.Learn more about ulcerative colitis
Baylor Scott & White Health is pleased to offer you multiple options to pay your bill. View our guide to understand your Baylor Scott & White billing statement.
Other payment options:
At Baylor Scott & White Health, we want to be a resource for you and your family. Our team of customer service representatives and financial counselors are here to help you find financial solutions that can help cover your cost of care. We encourage you to speak to a team member before, during or after care is received.
To ensure that your visit to our office is as convenient and efficient as possible, we are pleased to offer our registration forms online. The patient registration form may be completed electronically and printed for better legibility or completed manually.
Patient education and resources
- Capsule study prep
- Colonoscopy prep
- How to take Prepopik for colonoscopy
- How to take MoviPrep for colonoscopy
- Upper endoscopy (EGD) prep
Where to go for procedures
Truett Hospital, First Floor
Baylor University Medical Center Campus
News and media
Crohn's Disease Life Expectancy
Dr. Dassopoulos was recently interviewed by US News and World Report on the topic of mortality of Crohn's disease. Dr. Dassopoulos emphasized that the life span of individuals suffering from Crohn's disease is essentially the same as that of the general population.
IBS and IBD: More Than Just Tummy Trouble
Listen to Dr. Dassopoulos on KERA, Vital Signs series, explain the differences between IBS and IBD.
Ask the Expert: Irritable Bowel Syndrome and Inflammatory Bowel Disease (Part 1)
Dr Dassopoulos discusses the differences between Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD)
Watch the video
Ask the Expert: Irritable Bowel Syndrome and Inflammatory Bowel Disease (Part 2)
Dr. Dassopoulos educates on the most common symptoms, causes and therapies of IBD.
Watch the video
Medication cost assistance
Pharmaceutical companies offer patient assistance programs which provide assistance to those who need financial support in paying for their medication. Please note, these programs usually apply to those who are uninsured. To find information on various patient assistance programs providing assistance for specific medication, the links are:
BSWH patient education
Research and clinical trials
Baylor Scott & White Center for Inflammatory Bowel Diseases conducts a number of ongoing research studies that may benefit you, including clinical trials of medications that hold the promise of improving the health of patients with ulcerative colitis or Crohn's disease. To learn more, contact the Dallas clinical trials office at 214.818.9688.
The Center for IBD Research performs cutting-edge, impactful translational and basic research on IBD to improve our understanding of the disease and develop better treatments.
- Inflammatory bowel diseases and autophagy
- Crohn’s disease of the ileum
- Barrier function of the intestinal epithelium
- Colitis-associated colorectal cancer
- Intestinal stem cell responses to inflammation and diet
- Arianne L. Theiss, PhD, Research Director
- Themistocles Dassopoulos, MD, Medical Director
- Jie Han, MD, MS
Crohn's disease trials
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-and Active-Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Efficacy Assessor-Blinded study of Risankizumab Compared to Ustekinumab for the Treatment of Adult Subjects With Moderate to Severe Crohn’s Disease who have failed anti-TNF therapy
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy